Metsä Board, part of Metsä Group
Metsä Board, part of Metsä Group

Ensuring that vaccine vials and their potentially life-changing contents remain safe, sterile, and identifiable throughout their tightly controlled supply chain is no easy task, and taking risks is not an option. However, with the new extended 360 Service offering, Metsä Board, part of Metsä Group, tests the paperboards and simulates packaging designs used by pharma manufacturers to package and protect vaccine doses, providing absolute confidence that the materials are up to the task. 

COVID-19 and other vaccines are typically stored and transported in extremely cold conditions, which can be as low as -70 degrees celsius, before being thawed out ready for administration. Therefore, the secondary paperboard packaging must be able to withstand these temperature extremes and protect the vials throughout the entire process. 

Massive testing and simulation capabilities of Metsä Board

When a converter produces packages for cold-chain transportation, they must be 100% certain that the materials they are using are appropriate. This is where Metsä Board’s in-depth testing and simulation capabilities are extremely valuable for the pharma industry.

 Markku Leskelä, VP Research and Product Development, Metsä Board
Markku Leskelä, VP Research and Product Development, Metsä Board

Paperboard for pharma packaging needs to retain its specified thickness, mechanical strength, and water absorption properties regardless of the conditions it faces, and it must not affect the primary packaging in any way. Any changes in dimensions could cause curling or bulging, which could pose a risk to the integrity of the packaging and, therefore, the safety of the product inside. We are able to test paperboard and packaging samples in both extremely cold and extremely humid conditions, and develop packaging strength simulations to demonstrate how a package will perform in the real world,” Markku Leskelä, VP Research and Product Development, Metsä Board, says.

At its Excellence Centre in Äänekoski, central Finland, Metsä Board can test the performance of paperboard and pharmaceutical packaging samples across a wide temperature and humidity range. The conditions can be varied according to the specific needs of each case, and it is also possible to program different cyclic temperature and humidity changes to mimic the real-life conditions faced by vaccines as they travel along the supply chain

“With the help of a local partner, we can test packaging samples down to -70 degrees Celsius and combine transportation tests with board conditioning tests,” says Leskelä. “This kind of thorough research provides our customers with the confidence that the paperboard they want to use is appropriate for the application in question. And if the results show that it is not, we can recommend an alternative.” 

Metsä Board’s simulation capabilities include finite element (FEM) simulation, where it is possible to take a 3D design drawing or measure the dimensions of an existing package sample and use this structural data together with the strength data of the paperboard to calculate the strength of a complete packaging design. “With powerful computers and skilled personnel at our disposal, we can perform this kind of simulation within a single day to help speed up the process of getting a critical drug to market,” Leskelä highlights.

Packaging South Asia — resilient, growing and impactful — daily, monthly — always responsive

The multi-channel B2B in print and digital 17-year-old platform matches the industry’s growth trajectory. The Indian, South Asian, Southeast Asian, and Middle East packaging industries are looking beyond the resilience of the past three years. They are resuming capacity expansion and diversification, with high technology and automation in new plants and projects.

As we present our 2024 publishing plan, India’s real GDP growth for the financial year ending 31 March 2024 will exceed 6%. The packaging industry growth will match the GDP growth in volume terms and surpass it by at least 3% in terms of nominal growth allowing for price inflation in energy, raw materials, consumables, and capital equipment.

The capacity for flexible film manufacturing in India increased by 45% over the past four years. With orders in place, we expect another 20% capacity addition in 2024 and 2025. Capacities in monocartons, corrugation, aseptic liquid packaging, and labels are growing similarly. As the consumption story returns over the next six months, we expect demand to return and exceed the growth trajectory of previous years. The numbers are positive for most of the economies in the region – and as shown by our analytics, our platform increasingly reaches and influences these.

For responsible and sustainable packaging, with its attendant regulations and compliances, there is significant headroom to grow in India and the region. Our coverage includes the entire packaging supply chain – from concept to shelf and to waste collection, sorting, and recycling.

We target brand owners, product managers, raw material suppliers, packaging designers and converters, and recyclers. This is a large and complex canvas – the only thing that can work is your agile thinking and innovation together with our continuous learning and persistence.

The coming year looks to be an up year in this region, and this is the right time to plan your participation and marketing communication – in our rich and highly targeted business platform with human resources on the ground. Share your thoughts and plans to inspire and mobilize our editorial and advertising teams!

For editorial [email protected] — for advertisement [email protected] and for subscriptions [email protected]

– Naresh Khanna (25 October 2023)

Subscribe Now
unnamed 1

NEWSLETTER

Subscribe to our Newsletter

LEAVE A REPLY

Please enter your comment!
Please enter your name here